Evidence map›Paper›PMID 40407344›Full record

ArticleJournal of virology2025

Identification and characterization of O-GlcNAc modifications of a conserved orthopoxvirus core protein.

Yunliang Zhang, Bernard Moss

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yunliang ZhangLaboratory of Viral Diseases, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Bernard MossLaboratory of Viral Diseases, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.ORCID 0000-0002-2154-8564

Funding

NHLBI NIH HHS ZIAI000307
6 · The paper itself

Abstract

O-GlcNAcylation, a post-translational modification consisting of O-linked N-acetylglucosamine attached to serine and threonine residues, occurs in thousands of cytoplasmic, nuclear, and mitochondrial proteins but has been reported for relatively few viral proteins. We used click chemistry, specific antibodies, and mass spectrometry to investigate the O-GlcNAcylation of vaccinia virus (VACV) proteins. A virion protein of ~40 kDa was identified by SDS-polyacrylamide gel electrophoresis following azide-alkyne cycloaddition of biotin or an infrared dye to O-GlcNAc residues. Candidate O-GlcNAc virion proteins were detected by mass spectrometry, and A4, a highly conserved core component required for virion assembly, was identified by decreased electrophoretic mobility resulting from the specific attachment of multiple 10 kDa polyethylene glycol residues to O-GlcNAc sites. O-GlcNAc was not detected in virions of an A4 deletion mutant, suggesting A4 is the only or major constituent with this modification. Multiple O-GlcNAc modified amino acids in intrinsically disordered regions of A4 were identified by electron transfer dissociation mass spectrometry. Recombinant A4 was O-GlcNAcylated following stable and transient transfection of uninfected cell lines, suggesting a role for a cellular enzyme, which was confirmed by reduction of the modification by specific inhibitors of O-GlcNAc transferase during virus infection. Moreover, induced degradation of O-GlcNAc transferase prior to VACV infection decreased O-GlcNAcylation of A4 to undetectable levels without diminishing the A4 abundance. Nevertheless, the specific infectivity of O-GlcNAc-deficient virus particles was unimpaired. O-GlcNAcylation either has a subtle role in the VACV life cycle, or A4 is an inadvertent substrate of the promiscuous O-GlcNAc transferase.IMPORTANCEO-GlcNAc is a reversible enzymatic post-translational modification of serine and threonine residues found on thousands of cellular proteins with roles in regulating numerous functions including signal transduction, transcription, and stress response. However, little is known about O-GlcNAc modifications of viral proteins. Here, we report that the vaccinia virus A4 core protein has multiple O-GlcNAc modifications. The cellular O-GlcNAc transferase was shown to be required for modifying the vaccinia virus protein, which is synthesized and assembled into virus particles within cytoplasmic virus factories. Moreover, inhibition and degradation of the transferase prevented O-GlcNAcylation of A4. Nevertheless, virus assembly and replication

Indexed as

AcetylglucosamineProtein Processing, Post-TranslationalVaccinia virusViral ProteinsAnimalsCell LineGlycosylationHumansVirionAcetylglucosamineViral Proteinsglycosylationpost-translational modificationvaccinia virus

Identifiers

PMID40407344
PMCPMC12172419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.